David Paul Becker's Net Worth
$5.54 Million
Who is David Paul Becker?
David Paul Becker has an estimated net worth of $5.54 Million. This is based on reported shares across multiple companies, which include Adams Respiratory Therapeutics, Inc., MiddleBrook Pharmaceuticals, Inc., and PERNIX THERAPEUTICS HOLDINGS, INC..
SEC CIK
David Paul Becker's CIK is 0001332082
Past Insider Trading and Trends
2006 was David Paul Becker's most active year for acquiring shares with 6 total transactions. David Paul Becker's most active month to acquire stocks was the month of February. 2007 was David Paul Becker's most active year for disposing of shares, totalling 48 transactions. David Paul Becker's most active month to dispose stocks was the month of December. 2006 saw David Paul Becker paying a total of $218,607.30 for 110,253 shares, this is the most they've acquired in one year. In 2006 David Paul Becker cashed out on 177,890 shares for a total of $3,315,820.95, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adams Respiratory Therapeutics, Inc. No price found
CF & AODavid Paul Becker used to own units in Common Stock but no longer holds any shares there.acquired a total of 143,699 shares in Adams Respiratory Therapeutics, Inc. at a cost of $266,367.10, David also disposed a total of 147,683 shares of Adams Respiratory Therapeutics, Inc. equalling to $5,803,138.96.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -5.05K |
$44.74 | -$226,116.74 |
0
|
Scheduled
|
Jan 29
| ||
Form 4
|
∞
| 5.05K |
$22.93 | -$303,840.17 | 5.05K |
Scheduled
|
Jan 29
| ||
Form 4
|
—
|
0
|
$20.58 | -$70,826.90 |
0
|
Scheduled
|
Jan 3
| ||
Form 4
| -100.00% | -732.00 |
$41.23 | -$30,179.11 |
0
|
Scheduled
|
Nov 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
|
—
|
0
|
$29.68 | -$261,586.65 | 732 |
Scheduled
|
Jul 20
| ||
Form 4
| -67.16% | -1.50K |
$40.00 | -$59,880.00 | 732 |
Scheduled
|
Apr 3
| ||
Form 4
| -44.05% | -1.75K |
$18.07 | -$2,745,567.89 | 2.23K |
Scheduled
|
Mar 16 - Mar 17
| ||
Form 4
|
—
|
0
|
$22.22 | -$1,838,774.40 | 3.98K |
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MiddleBrook Pharmaceuticals, Inc. No price found
EVP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PERNIX THERAPEUTICS HOLDINGS, INC. No price found
Chief Financial OfficerDavid Paul Becker owns 200,000 units of Common Stock. In the year 2011 David Paul Becker acquired a total of 200,000 shares in PERNIX THERAPEUTICS HOLDINGS, INC..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 200K |
—
|
—
| 200K |
Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||